CBD oil pictured with an article about inflammation research

CBD and Inflammation UK: What Does the Research Show?

Is CBD Anti-Inflammatory?

CBD has shown anti-inflammatory effects in laboratory and animal research, but human evidence does not currently establish ordinary retail CBD oil as an anti-inflammatory treatment.

This distinction matters.

Researchers have found that cannabidiol can interact with biological pathways involved in inflammation, and that makes CBD a genuine subject of scientific interest.

However, recent reviews of human studies have found that changes in inflammatory biomarkers are generally inconsistent, small or uncertain, rather than showing a clear universal anti-inflammatory effect. Read the 2025 systematic review and meta-analysis on PubMed.

So it is reasonable to say:

CBD is being researched for its effects on inflammation.

It is not reasonable to say:

CBD oil has been proven to reduce inflammation in people.

For retail CBD products sold as foods in the UK, that distinction is especially important because the Food Standards Agency states that CBD foods have no authorised health claims and must not be promoted as treating illness or relieving medical symptoms. Read current FSA guidance.

What Is Inflammation?

Inflammation is part of the body's normal response to injury, infection and other forms of stress.

Short-term inflammation can be useful. It helps coordinate immune activity and repair.

Problems can arise when inflammatory activity becomes persistent or is associated with an underlying health condition.

Researchers often study this activity using substances called inflammatory biomarkers.

These can include signalling proteins known as cytokines, such as IL-6, IL-8, IL-10 and TNF-α.

Changes in these biomarkers can provide scientists with information about immune activity.

But an important point is often lost in online CBD discussions:

changing an inflammatory biomarker is not automatically the same as treating an inflammatory disease or making somebody feel better.

Why Do Scientists Study CBD and Inflammation?

CBD interacts with a complicated range of molecular targets.

Preclinical research has investigated pathways including NF-κB, NLRP3, PPAR-γ and different cytokine systems.

Animal experiments have repeatedly reported changes in inflammatory signalling after cannabinoid administration.

For example, a systematic review of 26 animal studies found that studies involving CBD frequently reported reductions in at least one pro-inflammatory cytokine. Read the preclinical systematic review on PubMed.

That is scientifically interesting.

But these were animal studies.

Results in cells, mice or rats cannot tell us with certainty what will happen when a person takes a retail CBD oil.

That process of moving from promising laboratory findings to reproducible effects in people is known as clinical translation — and that is where the evidence becomes much less clear.

What Does Human Research Show?

This is where the story becomes particularly interesting.

A 2025 systematic review and meta-analysis examined randomized evidence involving cannabinoids and inflammatory biomarkers.

Thirteen studies met the review criteria.

Researchers were able to combine results for several commonly studied biomarkers, including IL-6, IL-8, IL-10 and TNF-α.

The pooled estimates generally leaned in an anti-inflammatory direction, but the effects were small, statistically uncertain or imprecise.

For example, the combined IL-6 result was not statistically significant, nor were the combined IL-10 or TNF-α results.

The authors concluded that randomized evidence showed inconsistent and often trivial effects on circulating inflammatory biomarkers. Read the review on PubMed.

That is a much more cautious finding than the common internet claim that “CBD reduces inflammation.”

What Did the New 2026 Meta-Analysis Find?

An even larger systematic review and meta-analysis was published in Brain, Behavior, and Immunity in 2026.

It included 46 studies involving 54,382 participants.

Rather than finding a straightforward anti-inflammatory effect, researchers found evidence of a much more complex pattern.

In observational studies, cannabinoid use was associated with increases in both pro-inflammatory and anti-inflammatory biomarkers.

The randomized CBD evidence did not demonstrate a uniform anti-inflammatory effect either. The analysis suggested a small increase in pro-inflammatory markers, although the estimate was uncertain.

The researchers concluded that the overall evidence is more compatible with immune modulation than with cannabinoids simply pushing the immune system in one anti-inflammatory direction. Read the 2026 meta-analysis on PubMed.

This is an important development.

It does not prove that CBD has no relevant effects on inflammation.

It tells us that describing CBD simply as a “potent natural anti-inflammatory” is an oversimplification of what human research currently shows.

Have Any Human CBD Trials Found Anti-Inflammatory Effects?

Yes.

Individual human studies have produced interesting findings.

One randomized placebo-controlled study investigated CBD in people with cocaine-use disorder.

Participants received 800mg CBD per day or placebo, and blood samples from 48 participants were analysed.

Researchers found lower levels of several markers in the CBD group, including IL-6, and concluded that the findings suggested possible anti-inflammatory effects in this particular population. Read the randomized biomarker study on PubMed.

That is legitimate evidence and shouldn't be ignored.

But there are several reasons it cannot be turned into a claim about ordinary retail CBD oil.

The participants had cocaine-use disorder, which is associated with its own inflammatory and oxidative changes.

The researchers were investigating a very particular clinical population.

And 800mg per day is enormously different from ordinary UK consumer use.

The trial therefore tells researchers something interesting about CBD and inflammatory markers under specific experimental conditions.

It does not establish that taking Valley CBD oil reduces chronic inflammation.

Why Doesn't One Positive Study Settle the Question?

Because individual studies are only one part of the evidence.

Different CBD studies vary in dose, formulation, population, length of treatment, route of administration, health condition and biomarkers measured.

A positive change in one biomarker in one group of participants may not appear in another trial.

This is why systematic reviews and meta-analyses are so useful.

Rather than selecting one favourable CBD study, researchers combine and compare the wider evidence.

And when the current human evidence is looked at collectively, the picture remains mixed rather than conclusively anti-inflammatory.

Are Inflammatory Biomarkers the Same as Pain Relief?

No.

This is another important distinction.

Inflammation and pain can be related, but they are not interchangeable.

If a clinical trial records a change in IL-6, for example, that does not automatically prove that participants experienced less pain, better mobility or improvement in a particular disease.

Likewise, evidence involving pain cannot automatically establish that CBD reduced inflammation.

For that reason we keep these subjects separate.

Our CBD Oil and Pain UK guide examines human pain research specifically.

While this page owns the broader question: What does research show about CBD and inflammation?

What About CBD and Arthritis Inflammation?

Arthritis is often mentioned in discussions about CBD because several forms of arthritis involve inflammatory or degenerative processes.

But research involving arthritis needs to be considered on its own rather than assuming that general CBD mechanisms prove an effect.

Our separate CBD Oil for Arthritis UK article examines human oral and topical studies individually.

That research does not establish that retail CBD isolate treats arthritis or that a stronger CBD product produces a greater anti-inflammatory effect.

Keeping that distinction clear also stops this inflammation page competing unnecessarily with our arthritis page.

Does CBD Balm Reduce Inflammation?

Topical CBD is another active field of research.

Some human studies using particular topical CBD formulations have produced interesting results.

However, a study of one particular topical preparation cannot establish that every CBD balm is anti-inflammatory.

Different topical products can vary greatly in CBD concentration, ingredients, formulation and absorption.

There is currently not enough evidence to describe an ordinary retail CBD balm as a proven treatment for inflammation.

Our separate Does CBD Balm Work? article examines human topical CBD research rather than making a general medical claim.

Does Higher-Strength CBD Reduce More Inflammation?

There is no good clinical evidence showing that a higher-concentration retail CBD oil produces a greater anti-inflammatory effect simply because it contains more CBD per millilitre.

A 40% CBD oil is more concentrated than a 10% CBD oil.

That is an objective product characteristic.

It does not mean the 40% oil is four times as effective against inflammation.

Strength tells you concentration.

It does not tell you medical effectiveness.

The previous version of this article recommended high-strength CBD specifically for systemic inflammation.

That recommendation is not supported by the evidence and has been removed.

Anyone wanting to understand percentages, total CBD and mg/ml can use our separate CBD Oil Strength Guide.

Is CBD Isolate Better for Inflammation?

There is no clinical evidence establishing CBD isolate as superior to other CBD extract types for reducing inflammation.

“CBD isolate” describes the type of ingredient.

It tells you that the product is formulated using highly purified cannabidiol rather than relying on a wider spectrum of hemp compounds.

That can be useful product information.

But it should not be converted into a therapeutic claim.

The old article described Valley CBD isolate as providing a cleaner route to “systemic inflammatory relief.”

That wording has been removed.

We can explain honestly that Valley CBD oils use CBD isolate without claiming that isolate treats inflammation more effectively.

Is CBD a Powerful Antioxidant?

CBD has demonstrated antioxidant activity in laboratory and preclinical research, and scientists continue to investigate the biological importance of those effects. Read a review of CBD's biological effects.

But the previous article went much further.

It described CBD as providing a “daily shield” against cellular damage and linked this to joint stiffness, premature ageing and cognitive decline.

Those statements turn biochemical research into specific health-benefit claims that human evidence does not establish for retail CBD oil.

The more accurate position is:

CBD has antioxidant and inflammation-related biological properties that remain active areas of research.

That is interesting enough without promising health outcomes.

What About the Endocannabinoid System?

CBD research frequently involves the endocannabinoid system, but the relationship is more complicated than saying CBD simply “switches on” the ECS or uses it as a thermostat to turn inflammation off.

CBD has multiple molecular targets, and some of its effects may occur indirectly through endocannabinoid signalling and completely different receptor systems.

Recent human research also illustrates why simplistic ECS explanations should be treated carefully.

In one randomized trial using 800mg CBD per day, researchers found no sustained difference in plasma anandamide concentrations compared with placebo in people with cocaine-use disorder. Read the human CBD and anandamide study on PubMed.

So instead of saying CBD “switches off overactive inflammatory signals through the ECS,” we should explain that several possible mechanisms are being investigated and remain scientifically complex.

What Does the FSA Say About CBD Health Claims?

The Food Standards Agency updated its CBD guidance on 22 June 2026.

The FSA states that CBD foods currently have no authorised health claims.

It specifically says that claims that CBD food products relieve pain, improve sleep or treat illness are not permitted under UK regulations.

That means Valley CBD should not market an oil as an anti-inflammatory treatment, a treatment for chronic inflammation, a way to fight inflammation, or a product providing systemic inflammatory relief.

We can report scientific research.

We should not convert those studies into claims about what our products will do.

What Does the FSA Recommend About CBD Intake?

For healthy adults consuming CBD foods, the FSA currently advises a maximum intake of 10mg CBD per day.

It advises people under 18, people who are pregnant, breastfeeding or trying to conceive, and people taking medication to avoid CBD.

The FSA also says people with underlying health conditions should avoid CBD unless under appropriate medical direction.

This is consumer-safety guidance, not an inflammation-treatment dose.

Clinical research may use substantially higher doses, but those experimental doses should never be copied directly as instructions for using retail CBD products.

Frequently Asked Questions

Is CBD anti-inflammatory?

CBD has demonstrated anti-inflammatory effects in laboratory and animal research.

Human research is much less consistent. Recent systematic reviews have not established a clear, uniform anti-inflammatory effect from CBD in people.

Does CBD oil reduce inflammation?

There is not currently sufficient human evidence to say that ordinary retail CBD oil has been proven to reduce inflammation.

Has CBD been tested for inflammation in humans?

Yes.

Human studies have examined inflammatory biomarkers after CBD administration, and some individual trials have found potentially interesting changes.

However, pooled evidence remains inconsistent.

Is CBD good for chronic inflammation?

CBD should not be presented as a treatment for chronic inflammation.

Persistent inflammation can have many causes and may require appropriate medical investigation and treatment.

Is CBD balm anti-inflammatory?

Topical CBD is being researched, but there is not enough evidence to state that ordinary retail CBD balm is a proven anti-inflammatory treatment.

Does stronger CBD reduce more inflammation?

There is no good clinical evidence showing that a 40% retail CBD oil reduces inflammation more effectively than a lower concentration simply because it contains more CBD.

How much CBD should I take for inflammation?

There is no established retail CBD treatment dose for inflammation.

Clinical-study doses are not consumer instructions.

For CBD foods generally, current FSA guidance advises healthy adults not to exceed 10mg CBD per day.

Can CBD replace anti-inflammatory medicine?

Retail CBD should not be used as a substitute for prescribed or recommended medical treatment.

Anyone concerned about persistent inflammation, pain or an underlying condition should seek appropriate medical advice.

The Bottom Line

CBD and inflammation is a genuine area of scientific research.

Laboratory and animal studies provide substantial evidence that cannabidiol can influence inflammatory pathways, which explains why researchers remain interested in its potential.

But human evidence is much more complicated.

A 2025 systematic review found randomized effects on major inflammatory biomarkers were generally small, imprecise or inconsistent. A larger 2026 analysis similarly found no simple anti-inflammatory pattern and described cannabinoid effects as more consistent with broader immune modulation.

Individual human trials have produced interesting findings, but their doses, participants and experimental conditions cannot automatically be applied to retail CBD products.

So the evidence today supports saying:

CBD affects biological pathways involved in inflammation and remains an active research subject.

It does not support saying:

Valley CBD oil or balm is a proven anti-inflammatory treatment.

That distinction allows us to discuss the science properly without making promises the evidence cannot support.

This article is for general educational information only and is not medical advice. Valley CBD food supplements are not intended to diagnose, treat, cure or prevent disease.

Sources

Back to blog